Update of molecular pathobiology in oral cancer: a review
- 25 March 2014
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 19 (3) , 431-436
Abstract
Head and neck cancer including oral squamous cell carcinoma (OSCC) is the sixth most common cancer in the world. OSCC has a high potential for local invasion and nodal metastasis, and the overall 5-year survival rate has not significantly changed during the past 30 years. Recent research has elucidated the detailed molecular mechanisms of carcinogenesis, tumor progression, and metastasis of OSCC. It is generally accepted that OSCC arises from multiple genetic alterations caused by chronic exposure to carcinogens such as alcohol, smoking, viral infections, and inflammation. The molecular mechanisms of carcinogenesis, tumor progression, and metastasis of head and neck cancer have been elucidated by recent advances in molecular biology. However, many unsolved questions remain. In this review, we describe the current molecular biological findings such as human papillomavirus infection, epithelial–mesenchymal transition, microRNA, and our novel molecular pathological findings of OSCC.Keywords
This publication has 67 references indexed in Scilit:
- Transforming growth factor-β1 treatment of oral cancer induces epithelial-mesenchymal transition and promotes bone invasion via enhanced activity of osteoclastsClinical & Experimental Metastasis, 2013
- Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patientsGenes, Chromosomes and Cancer, 2012
- MicroRNA-138 suppresses epithelial–mesenchymal transition in squamous cell carcinoma cell linesBiochemical Journal, 2011
- Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirusHead & Neck, 2011
- MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cellsBiochemical Journal, 2010
- Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell CarcinomaPLOS ONE, 2010
- MicroRNA‐24 targeting RNA‐binding protein DND1 in tongue squamous cell carcinomaFEBS Letters, 2010
- Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosisJournal of Clinical Investigation, 2010
- Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer DetectionClinical Cancer Research, 2009
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001